• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

戈谢氏病 1 型的神经表现:法国戈谢氏病观察站(FROG)。

The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG).

机构信息

Médecine Interne, Hôpital de la Pitié-Salpêtrière, Paris, France.

出版信息

J Inherit Metab Dis. 2010 Aug;33(4):331-8. doi: 10.1007/s10545-010-9095-5. Epub 2010 Jun 2.

DOI:10.1007/s10545-010-9095-5
PMID:20532983
Abstract

BACKGROUND

Gaucher disease (GD), the most prevalent inherited lysosomal storage disorder, is caused by deficient glucocerebrosidase activity. Type 1 GD (GD1), the most common variant, is classically considered non-neuronopathic.

METHODS

We performed a national cross-sectional observational survey-the French Observatoire on Gaucher Disease (FROG)-in patients with GD1 between March 2005 and September 2006. The study included all patients over 18 years of age with confirmed GD1 who attended participating centers for regular follow-up.

RESULTS

One hundred and five patients were included, in whom we studied the prevalence and characteristics of relevant neurological symptoms associated with the neuraxis. Of these, 51 (49%) GD1 patients presented at least one neurological symptom. Four patients (4%) had Parkinson disease and 22 (21%) presented with at least one parkinsonian sign or at least one sign frequently associated with Parkinson disease. Five patients (5%) had a previous diagnosis of peripheral neuropathy. Other central nervous system symptoms were recorded in 20 (19%) patients and other peripheral nervous system symptoms in 39 (37%) patients.

CONCLUSIONS

These data challenge the current classification of GD, and suggest that the three forms of GD each involve a different profile of neurological manifestations.

摘要

背景

戈谢病(GD)是最常见的遗传性溶酶体贮积病,由葡糖脑苷脂酶活性缺乏引起。最常见的变异类型 1 型 GD(GD1)通常被认为是非神经病变型。

方法

我们在 2005 年 3 月至 2006 年 9 月期间开展了一项全国性的戈谢病观察性研究——法国戈谢病观察站(FROG),该研究纳入了 GD1 患者。研究纳入了所有在参与中心接受常规随访、确诊为 GD1 且年龄大于 18 岁的患者。

结果

共纳入了 105 例患者,我们研究了与中枢神经系统相关的、具有神经轴相关性的相关神经症状的患病率和特征。其中,51 例(49%)GD1 患者存在至少一种神经症状。4 例(4%)患者患有帕金森病,22 例(21%)患者存在至少一个帕金森症体征或至少一个常与帕金森病相关的体征。5 例(5%)患者有周围神经病变的既往诊断。20 例(19%)患者记录了其他中枢神经系统症状,39 例(37%)患者记录了其他周围神经系统症状。

结论

这些数据对目前的 GD 分类提出了挑战,并提示三种类型的 GD 各自涉及不同的神经表现特征。

相似文献

1
The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG).戈谢氏病 1 型的神经表现:法国戈谢氏病观察站(FROG)。
J Inherit Metab Dis. 2010 Aug;33(4):331-8. doi: 10.1007/s10545-010-9095-5. Epub 2010 Jun 2.
2
A Brazilian Rare-Disease Center's Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF.巴西一家罕见病中心对戈谢病患者使用葡萄糖神经酰胺(溶血神经酰胺1)的经验:探索与血浆中IgG水平的新关联以及脑脊液中的生物标志物测量
Int J Mol Sci. 2024 Mar 1;25(5):2870. doi: 10.3390/ijms25052870.
3
The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry.1 型戈谢病患者帕金森病的发病率:来自 ICGG 戈谢病登记处的数据。
Blood Cells Mol Dis. 2011 Jan 15;46(1):95-102. doi: 10.1016/j.bcmd.2010.10.006. Epub 2010 Nov 10.
4
Vertebral fractures in Gaucher disease type I: data from the French "Observatoire" on Gaucher disease (FROG).戈谢氏病 I 型的脊柱骨折:来自法国戈谢氏病观察站(FROG)的数据。
Osteoporos Int. 2011 Apr;22(4):1255-61. doi: 10.1007/s00198-010-1342-y. Epub 2010 Aug 4.
5
'Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature.重新审视“非神经病变型”戈谢病。荷兰一组I型戈谢病患者神经学表现的患病率及文献系统综述
J Inherit Metab Dis. 2008 Jun;31(3):337-49. doi: 10.1007/s10545-008-0832-y. Epub 2008 Apr 4.
6
Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism.戈谢氏病和帕金森病伴发戈谢氏病的神经病理学特征。
Int J Mol Sci. 2022 May 23;23(10):5842. doi: 10.3390/ijms23105842.
7
The risk of Parkinson's disease in type 1 Gaucher disease.1 型戈谢病患者罹患帕金森病的风险。
J Inherit Metab Dis. 2010 Apr;33(2):167-73. doi: 10.1007/s10545-010-9055-0. Epub 2010 Feb 23.
8
Pediatric Gaucher disease with intermediate type 2-3 phenotype associated with parkinsonian features and levodopa responsiveness.儿童中间型 2-3 型 Gaucher 病伴帕金森特征和左旋多巴反应性。
Parkinsonism Relat Disord. 2021 Oct;91:19-22. doi: 10.1016/j.parkreldis.2021.08.010. Epub 2021 Aug 19.
9
Novel hyperkinetic dystonia-like manifestation and neurological disease course of Swedish Gaucher patients.瑞典戈谢病患者的新型运动亢进性肌张力障碍样表现及神经疾病病程
Blood Cells Mol Dis. 2018 Feb;68:86-92. doi: 10.1016/j.bcmd.2016.10.011. Epub 2016 Oct 21.
10
Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study.成人 1 型戈谢病中的周围神经病:一项为期 2 年的前瞻性观察研究。
Brain. 2010 Oct;133(10):2909-19. doi: 10.1093/brain/awq198. Epub 2010 Aug 7.

引用本文的文献

1
Old disease-New reflections: Gaucher, immunity, and inflammation.旧疾新思:戈谢病、免疫与炎症。
J Cell Mol Med. 2024 Oct;28(20):e70087. doi: 10.1111/jcmm.70087.
2
Neurological symptoms in adults with Gaucher disease: a systematic review.成人戈谢病的神经系统症状:系统评价。
J Neurol. 2024 Jul;271(7):3897-3907. doi: 10.1007/s00415-024-12439-5. Epub 2024 May 21.
3
A global neuronopathic gaucher disease registry (GARDIAN): a patient-led initiative.全球神经病变戈谢病登记处(GARDIAN):一项患者主导的倡议。

本文引用的文献

1
Monoclonal gammopathy and neuropathy.单克隆丙种球蛋白病与神经病变。
Curr Opin Neurol. 2009 Oct;22(5):480-5. doi: 10.1097/WCO.0b013e32832fd563.
2
Gaucher disease and monoclonal gammopathy: a report of 17 cases and impact of therapy.戈谢病与单克隆丙种球蛋白病:17例报告及治疗影响
Blood Cells Mol Dis. 2009 Jul-Aug;43(1):138-9. doi: 10.1016/j.bcmd.2009.04.002. Epub 2009 May 8.
3
Goal-oriented therapy with miglustat in Gaucher disease.戈谢病中使用米格鲁司他的目标导向治疗。
Orphanet J Rare Dis. 2023 Jul 21;18(1):195. doi: 10.1186/s13023-023-02828-w.
4
The Spectrum of Neurological and Sensory Abnormalities in Gaucher Disease Patients: A Multidisciplinary Study (SENOPRO).《戈谢病患者神经系统和感觉异常的范围:一项多学科研究(SENOPRO)》。
Int J Mol Sci. 2023 May 16;24(10):8844. doi: 10.3390/ijms24108844.
5
Neuronopathic Gaucher disease models reveal defects in cell growth promoted by Hippo pathway activation.神经病变型戈谢病模型揭示 Hippo 通路激活促进的细胞生长缺陷。
Commun Biol. 2023 Apr 19;6(1):431. doi: 10.1038/s42003-023-04813-2.
6
Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1.患者为中心的戈谢病 1 型实验室诊断指南。
Orphanet J Rare Dis. 2022 Dec 21;17(1):442. doi: 10.1186/s13023-022-02573-6.
7
Gaucher disease in North Macedonia: Unexpected prevalence of the N370S GBA1 allele with attenuated disease expression.北马其顿的戈谢病:N370S GBA1等位基因意外的高流行率及疾病表达减弱
Mol Genet Metab Rep. 2022 Jul 8;32:100895. doi: 10.1016/j.ymgmr.2022.100895. eCollection 2022 Sep.
8
Phenotype Expansion for Atypical Gaucher Disease Due to Homozygous Missense PSAP Variant in a Large Consanguineous Pakistani Family.由于在一个大型近亲巴基斯坦家族中存在 PSAP 错义变异的纯合子,导致非典型戈谢病的表型扩展。
Genes (Basel). 2022 Apr 9;13(4):662. doi: 10.3390/genes13040662.
9
Gaucher disease - more than just a rare lipid storage disease.戈谢病——不仅仅是一种罕见的脂质贮积病。
J Mol Med (Berl). 2022 Apr;100(4):499-518. doi: 10.1007/s00109-021-02174-z. Epub 2022 Jan 23.
10
Trends in Glucocerebrosides Research: A Systematic Review.葡萄糖脑苷脂研究趋势:一项系统综述。
Front Physiol. 2020 Oct 29;11:558090. doi: 10.3389/fphys.2020.558090. eCollection 2020.
Curr Med Res Opin. 2009 Jan;25(1):23-37. doi: 10.1185/03007990802576518.
4
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset.GBA基因突变与帕金森病风险及发病之间的基因型-表型相关性。
Neurology. 2008 Jun 10;70(24):2277-83. doi: 10.1212/01.wnl.0000304039.11891.29. Epub 2008 Apr 23.
5
'Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature.重新审视“非神经病变型”戈谢病。荷兰一组I型戈谢病患者神经学表现的患病率及文献系统综述
J Inherit Metab Dis. 2008 Jun;31(3):337-49. doi: 10.1007/s10545-008-0832-y. Epub 2008 Apr 4.
6
Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature.I型戈谢病中的免疫球蛋白和游离轻链异常:来自63例成年患者队列的数据及文献综述
Ann Hematol. 2008 Jun;87(6):439-49. doi: 10.1007/s00277-008-0441-8. Epub 2008 Feb 15.
7
The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease.自噬-溶酶体途径在帕金森病相关神经退行性变中的作用。
Brain. 2008 Aug;131(Pt 8):1969-78. doi: 10.1093/brain/awm318. Epub 2008 Jan 10.
8
Neurological evaluation of patients with Gaucher disease diagnosed as type 1.对诊断为1型戈谢病患者的神经学评估。
J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):219-22. doi: 10.1136/jnnp.2006.111518. Epub 2007 Aug 6.
9
Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease.来自中国台湾地区散发性帕金森病患者的葡萄糖脑苷脂酶突变
Mol Genet Metab. 2007 Jun;91(2):195-200. doi: 10.1016/j.ymgme.2007.03.004. Epub 2007 Apr 25.
10
Are symptoms of peripheral neuropathy more prevalent in patients with Gaucher disease?戈谢病患者周围神经病变的症状是否更普遍?
Acta Neurol Scand. 2007 Apr;115(4):275-8. doi: 10.1111/j.1600-0404.2006.00774.x.